Maynard, MA, United States of America

Kelley C Shortsleeves

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 10.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Work of Kelley C. Shortsleeves

Introduction

Kelley C. Shortsleeves, a distinguished inventor based in Maynard, MA, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of five patents, her work primarily focuses on the development of SHP2 phosphatase inhibitors, presenting new horizons for treating related disorders.

Latest Patents

Kelley’s latest patents include groundbreaking innovations related to SHP2 phosphatase inhibitors. Her first patent outlines novel compounds and pharmaceutical compositions that effectively inhibit the activity of SHP2 phosphatase. This patent not only details these innovative compounds but also discusses their potential methods of use in treating disorders associated with SHP2 deregulation. Similarly, her second patent expands on this foundation, further elaborating on the compounds and methods to provide enhanced treatment options for various disorders related to this phosphatase.

Career Highlights

Throughout her career, Kelley has worked with notable companies that are at the forefront of biomedical research and innovation. Most prominently, she has been associated with Relay Therapeutics, Inc. and D.E. Shaw Research, LLC. These positions have allowed her to collaborate on pioneering research projects, leveraging her expertise in the pharmaceutical domain to drive significant advancements.

Collaborations

Kelley’s innovative journey has been enriched by collaborations with accomplished professionals in her field. Among her coworkers are Alexander M. Taylor and André Lescarbeau, both of whom have contributed valuable insights and support to her research endeavors. Together, they have fostered a dynamic environment that promotes creativity and scientific exploration.

Conclusion

Kelley C. Shortsleeves embodies the spirit of innovation in the realm of pharmaceutical sciences. Her relentless pursuit of knowledge and commitment to advancing medical treatments through her patents on SHP2 phosphatase inhibitors position her as a leading figure in her field. As research continues to evolve, Kelley's contributions will undoubtedly leave a lasting impact on healthcare and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…